362 related articles for article (PubMed ID: 14627652)
1. Emerging role for autophagy in the removal of aggresomes in Schwann cells.
Fortun J; Dunn WA; Joy S; Li J; Notterpek L
J Neurosci; 2003 Nov; 23(33):10672-80. PubMed ID: 14627652
[TBL] [Abstract][Full Text] [Related]
2. Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations.
Ryan MC; Shooter EM; Notterpek L
Neurobiol Dis; 2002 Jul; 10(2):109-18. PubMed ID: 12127149
[TBL] [Abstract][Full Text] [Related]
3. The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones.
Fortun J; Verrier JD; Go JC; Madorsky I; Dunn WA; Notterpek L
Neurobiol Dis; 2007 Feb; 25(2):252-65. PubMed ID: 17174099
[TBL] [Abstract][Full Text] [Related]
4. Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model.
Fortun J; Li J; Go J; Fenstermaker A; Fletcher BS; Notterpek L
J Neurochem; 2005 Mar; 92(6):1531-41. PubMed ID: 15748170
[TBL] [Abstract][Full Text] [Related]
5. Inducible HSP70 is critical in preventing the aggregation and enhancing the processing of PMP22.
Chittoor-Vinod VG; Lee S; Judge SM; Notterpek L
ASN Neuro; 2015; 7(1):. PubMed ID: 25694550
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy.
Notterpek L; Shooter EM; Snipes GJ
J Neurosci; 1997 Jun; 17(11):4190-200. PubMed ID: 9151736
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of protein quality control mechanisms during disease progression in the C22 mouse model of CMT1A.
Chittoor VG; Sooyeon L; Rangaraju S; Nicks JR; Schmidt JT; Madorsky I; Narvaez DC; Notterpek L
ASN Neuro; 2013 Dec; 5(5):e00128. PubMed ID: 24175617
[TBL] [Abstract][Full Text] [Related]
8. Colocalization Analysis of Peripheral Myelin Protein-22 and Lamin-B1 in the Schwann Cell Nuclei of Wt and TrJ Mice.
Di Tomaso MV; Vázquez Alberdi L; Olsson D; Cancela S; Fernández A; Rosillo JC; Reyes Ábalos AL; Álvarez Zabaleta M; Calero M; Kun A
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327648
[TBL] [Abstract][Full Text] [Related]
9. Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction.
Tobler AR; Notterpek L; Naef R; Taylor V; Suter U; Shooter EM
J Neurosci; 1999 Mar; 19(6):2027-36. PubMed ID: 10066256
[TBL] [Abstract][Full Text] [Related]
10. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression.
Fortun J; Go JC; Li J; Amici SA; Dunn WA; Notterpek L
Neurobiol Dis; 2006 Apr; 22(1):153-64. PubMed ID: 16326107
[TBL] [Abstract][Full Text] [Related]
11. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
12. Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina.
Amici SA; Dunn WA; Murphy AJ; Adams NC; Gale NW; Valenzuela DM; Yancopoulos GD; Notterpek L
J Neurosci; 2006 Jan; 26(4):1179-89. PubMed ID: 16436605
[TBL] [Abstract][Full Text] [Related]
13. Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiology.
Vanoye CG; Sakakura M; Follis RM; Trevisan AJ; Narayan M; Li J; Sanders CR; Carter BD
J Biol Chem; 2019 Aug; 294(32):12054-12065. PubMed ID: 31213528
[TBL] [Abstract][Full Text] [Related]
14. Development of early postnatal peripheral nerve abnormalities in Trembler-J and PMP22 transgenic mice.
Robertson AM; Huxley C; King RH; Thomas PK
J Anat; 1999 Oct; 195 ( Pt 3)(Pt 3):331-9. PubMed ID: 10580849
[TBL] [Abstract][Full Text] [Related]
15. PMP22 accumulation in aggresomes: implications for CMT1A pathology.
Notterpek L; Ryan MC; Tobler AR; Shooter EM
Neurobiol Dis; 1999 Oct; 6(5):450-60. PubMed ID: 10527811
[TBL] [Abstract][Full Text] [Related]
16. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
[TBL] [Abstract][Full Text] [Related]
17. PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells.
Colby J; Nicholson R; Dickson KM; Orfali W; Naef R; Suter U; Snipes GJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):561-73. PubMed ID: 11114256
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition suppresses Schwann cell dedifferentiation in vitro and in vivo.
Lee HK; Shin YK; Jung J; Seo SY; Baek SY; Park HT
Glia; 2009 Dec; 57(16):1825-34. PubMed ID: 19455715
[TBL] [Abstract][Full Text] [Related]
19. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein.
Taylor JP; Tanaka F; Robitschek J; Sandoval CM; Taye A; Markovic-Plese S; Fischbeck KH
Hum Mol Genet; 2003 Apr; 12(7):749-57. PubMed ID: 12651870
[TBL] [Abstract][Full Text] [Related]
20. Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells.
Pareek S; Suter U; Snipes GJ; Welcher AA; Shooter EM; Murphy RA
J Biol Chem; 1993 May; 268(14):10372-9. PubMed ID: 8486695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
